Pharmaceutical Institute (PHI) completes acquisition by Kelix Bio
KELIX bio, a pan-African biopharmaceutical platform, has entered into a binding agreement to acquire Moroccan Pharmaceutical Institute (“PHI”). This investment marks KELIX bio’s first entry into Morocco – an important market in the company’